Metformin-SGLT2, Dehydration, and Acidosis Potential.

Area of Science:

• Endocrinology
• Geriatrics
• Pharmacology

Background:

• Metformin is a widely used first-line treatment for type 2 diabetes mellitus.
• Established risks include lactic acidosis, particularly in patients with impaired renal function.
• Geriatric populations are especially vulnerable due to age-related physiological changes.

Observation:

• A new class of antidiabetic agents increases urinary glucose excretion (glycosuria).
• This mechanism can lead to dehydration and electrolyte imbalances.
• Concomitant use with metformin, which can cause diarrhea, and diuretics, which promote fluid loss, exacerbates these risks.

Findings:

• The combination of glycosuria-inducing agents with metformin and/or diuretics presents a significant risk for dehydration and acidosis in elderly patients.
• Gastrointestinal losses from metformin-induced diarrhea and urinary losses from diuretics contribute to fluid and electrolyte disturbances.
• A case illustration highlights the potential severity of these combined adverse effects.

Implications:

• Clinicians must carefully assess renal function and hydration status in geriatric patients with type 2 diabetes initiating or on these medications.
• Risk-benefit analysis is crucial when considering glycosuria-inducing agents in conjunction with metformin, especially in the elderly.
• Enhanced monitoring for dehydration and acidosis is recommended to prevent severe complications.